Trial intelligence / Profile preview

Granisetron pre-administration and norepinephrine ED50 for prevention of induction hypotension in elderly laparoscopic gastrointestinal surgery

ChiCTR2200061900Phase 4Not yet recruiting

Sponsor
Sir Run-Run Shaw Hospital
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of granisetron and norepinephrine in intraoperative hypotension (IOH) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: mean arterial pressure, blood pressure and 4 more. Planned start Jul 2022; status: not yet recruiting.

02

Drugs

granisetronnorepinephrine
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on ChiCTR2200061900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200061900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call